Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Venetoclax And Other New Kids On The Block Shine At ASH

Executive Summary

Emerging drugs for chronic lymphocytic leukemia include Roche/AbbVie’s venetoclax (ABT-199), Acerta’s ACP-196, Merck’s Keytruda and MorPhoSys’ MOR208.

Advertisement

Related Content

ASH 2016 Preview: Don't Miss These 10 Data Presentations

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register